These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 8980676
1. Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. Burke DH, Scates L, Andrews K, Gold L. J Mol Biol; 1996 Dec 13; 264(4):650-66. PubMed ID: 8980676 [Abstract] [Full Text] [Related]
2. Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. Green L, Waugh S, Binkley JP, Hostomska Z, Hostomsky Z, Tuerk C. J Mol Biol; 1995 Mar 17; 247(1):60-8. PubMed ID: 7534830 [Abstract] [Full Text] [Related]
3. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase. Gao HQ, Boyer PL, Sarafianos SG, Arnold E, Hughes SH. J Mol Biol; 2000 Jul 07; 300(2):403-18. PubMed ID: 10873473 [Abstract] [Full Text] [Related]
4. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase. Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A. Arch Biochem Biophys; 2007 Feb 15; 458(2):202-12. PubMed ID: 17257575 [Abstract] [Full Text] [Related]
5. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr). Gleenberg IO, Herschhorn A, Hizi A. J Mol Biol; 2007 Jun 22; 369(5):1230-43. PubMed ID: 17490682 [Abstract] [Full Text] [Related]
6. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). Joshi P, Prasad VR. J Virol; 2002 Jul 22; 76(13):6545-57. PubMed ID: 12050367 [Abstract] [Full Text] [Related]
7. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision. Boyer PL, Imamichi T, Sarafianos SG, Arnold E, Hughes SH. J Virol; 2004 Sep 22; 78(18):9987-97. PubMed ID: 15331732 [Abstract] [Full Text] [Related]
8. Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate. Quiñones-Mateu ME, Soriano V, Domingo E, Menéndez-Arias L. Virology; 1997 Sep 29; 236(2):364-73. PubMed ID: 9325244 [Abstract] [Full Text] [Related]
9. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN. J Virol; 2004 Dec 29; 78(24):13553-61. PubMed ID: 15564466 [Abstract] [Full Text] [Related]
10. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs. Auwerx J, Van Nieuwenhove J, Rodríguez-Barrios F, de Castro S, Velázquez S, Ceccherini-Silberstein F, De Clercq E, Camarasa MJ, Perno CF, Gago F, Balzarini J. FEBS Lett; 2005 Apr 25; 579(11):2294-300. PubMed ID: 15848161 [Abstract] [Full Text] [Related]
11. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus. Chen H, McBroom DG, Zhu YQ, Gold L, North TW. Biochemistry; 1996 May 28; 35(21):6923-30. PubMed ID: 8639644 [Abstract] [Full Text] [Related]
12. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors. Auwerx J, Esnouf R, De Clercq E, Balzarini J. Mol Pharmacol; 2004 Jan 28; 65(1):244-51. PubMed ID: 14722257 [Abstract] [Full Text] [Related]
14. Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase. Zhou Z, Madrid M, Madura JD. Proteins; 2002 Dec 01; 49(4):529-42. PubMed ID: 12402361 [Abstract] [Full Text] [Related]
16. Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase. Sato H, Tomita Y, Ebisawa K, Hachiya A, Shibamura K, Shiino T, Yang R, Tatsumi M, Gushi K, Umeyama H, Oka S, Takebe Y, Nagai Y. J Virol; 2001 Jun 01; 75(12):5604-13. PubMed ID: 11356968 [Abstract] [Full Text] [Related]
17. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication. Li TK, Barbieri CM, Lin HC, Rabson AB, Yang G, Fan Y, Gaffney BL, Jones RA, Pilch DS. Biochemistry; 2004 Aug 03; 43(30):9732-42. PubMed ID: 15274628 [Abstract] [Full Text] [Related]
18. Rational approaches for the design of effective human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitors. Ribone SR, Quevedo MA, Madrid M, Briñón MC. J Chem Inf Model; 2011 Jan 24; 51(1):130-8. PubMed ID: 21133347 [Abstract] [Full Text] [Related]
19. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. Roth T, Morningstar ML, Boyer PL, Hughes SH, Buckheit RW, Michejda CJ. J Med Chem; 1997 Dec 19; 40(26):4199-207. PubMed ID: 9435891 [Abstract] [Full Text] [Related]
20. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase. Gao HQ, Sarafianos SG, Arnold E, Hughes SH. J Mol Biol; 1999 Dec 17; 294(5):1097-113. PubMed ID: 10600369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]